Publications
5674 Results
- Journal / Conference
- Annals of Oncology Mar;16(3):425-429
- Year
- 2005
- Research Committee(s)
- Gastrointestinal
- PMC
- PMID15677624
- Study Number(s)
- N9741
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
- Journal / Conference
- Investigational New Drugs 22:335-341
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9100
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group study
- Journal / Conference
- Controlled Clinical Trials 2:203-222
- Year
- 2004
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
Implementation of the prostate cancer prevention trial (PCPT)
- Journal / Conference
- Investigational New Drugs 22:91-97
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S9801
Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group study
- Journal / Conference
- Gynecologic Oncology 94:98-106
- Year
- 2004
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9106
Randomized phase II trial of two high dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study
- Journal / Conference
- British Journal of Haematology 124:481-484
- Year
- 2004
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031
Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukemia
- Journal / Conference
- Cancer 100(4):818-825
- Year
- 2004
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-9139
Adjuvant therapy of osteosarcoma, a phase II trial Southwest Oncology Group study 9139
- Journal / Conference
- Investigational New Drugs 22:467-473
- Year
- 2004
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-9107
A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: A Southwest Oncology Group study
- Journal / Conference
- International Journal of Gynecologic Cancer 14:224-228
- Year
- 2004
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-9326